Israeli companies start trials for treating Covid-19 with Cannabis

Israeli companies start trials for treating Covid-19 with Cannabis

Clinical trials have started by two Israeli companies to see if CBD combined with other drugs could save lives threatened by Covid-19.

“We estimate that our CBD-based treatment can enhance the current treatment of those patients who are in life-threatening conditions,” said David Bass, Stero Biotech’s founder and CEO, in a press release.

“Hospitalized COVID-19 patients are mostly being treated with steroids, and our study is planned to demonstrate the benefit of a combined solution with steroid treatments. We are hopeful that this study will lead to faster benefit for the growing number of COVID-19 patients in Israel and around the world.”

A second CBD clinical trial is being conducted through partnership between the University of Tel Aviv and InnoCan Pharma. And this one is a bit unconventional: The treatment will deliver CBD through exosomes. Exosomes are cell structures created by stem cells when they multiply.